139 related articles for article (PubMed ID: 38089143)
1. Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes.
Luinenburg MJ; Scheper M; Sørensen FNF; Anink JJ; Van Hecke W; Korshunova I; Jansen FE; Riney K; van Eijsden P; Gosselaar P; Mills JD; Kalf RS; Zimmer TS; Broekaart DWM; Khodosevich K; Aronica E; Mühlebner A
Front Cell Neurosci; 2023; 17():1284394. PubMed ID: 38089143
[TBL] [Abstract][Full Text] [Related]
2. Astroglial calcium signaling and homeostasis in tuberous sclerosis complex.
Romagnolo A; Dematteis G; Scheper M; Luinenburg MJ; Mühlebner A; Van Hecke W; Manfredi M; De Giorgis V; Reano S; Filigheddu N; Bortolotto V; Tapella L; Anink JJ; François L; Dedeurwaerdere S; Mills JD; Genazzani AA; Lim D; Aronica E
Acta Neuropathol; 2024 Feb; 147(1):48. PubMed ID: 38418708
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M; Crino PB
Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
[TBL] [Abstract][Full Text] [Related]
4. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
[TBL] [Abstract][Full Text] [Related]
5. Neuron-Glia Interactions in Tuberous Sclerosis Complex Affect the Synaptic Balance in 2D and Organoid Cultures.
Dooves S; van Velthoven AJH; Suciati LG; Heine VM
Cells; 2021 Jan; 10(1):. PubMed ID: 33445520
[TBL] [Abstract][Full Text] [Related]
6. Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis.
Zimmer TS; Broekaart DWM; Gruber VE; van Vliet EA; Mühlebner A; Aronica E
Front Neurol; 2020; 11():1028. PubMed ID: 33041976
[TBL] [Abstract][Full Text] [Related]
7. Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex.
Short B; Kozek L; Harmsen H; Zhang B; Wong M; Ess KC; Fu C; Naftel R; Pearson MM; Carson RP
Neurobiol Dis; 2019 Sep; 129():93-101. PubMed ID: 31078684
[TBL] [Abstract][Full Text] [Related]
8. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
Zeng LH; Bero AW; Zhang B; Holtzman DM; Wong M
Neurobiol Dis; 2010 Mar; 37(3):764-71. PubMed ID: 20045054
[TBL] [Abstract][Full Text] [Related]
9. The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex.
Wong M
J Neurodev Disord; 2019 Dec; 11(1):30. PubMed ID: 31838997
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
11. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures.
van Scheppingen J; Iyer AM; Prabowo AS; Mühlebner A; Anink JJ; Scholl T; Feucht M; Jansen FE; Spliet WG; Krsek P; Zamecnik J; Buccoliero AM; Giordano F; Genitori L; Kotulska K; Jozwiak S; Jaworski J; Liszewska E; van Vliet EA; Aronica E
Glia; 2016 Jun; 64(6):1066-82. PubMed ID: 27014996
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis: a primary pathology of astrocytes?
Sosunov AA; Wu X; Weiner HL; Mikell CB; Goodman RR; Crino PD; McKhann GM
Epilepsia; 2008; 49 Suppl 2():53-62. PubMed ID: 18226172
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex.
Zhang B; McDaniel SS; Rensing NR; Wong M
PLoS One; 2013; 8(2):e57445. PubMed ID: 23437388
[TBL] [Abstract][Full Text] [Related]
14. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
15. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
[TBL] [Abstract][Full Text] [Related]
16. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
[TBL] [Abstract][Full Text] [Related]
18. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
Zou J; Zhang B; Gutmann DH; Wong M
Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
